Breast Cancer: A Global Concern, Diagnostic and Therapeutic Perspectives, Mechanistic Targets in Drug Development

Gul-E-Saba Chaudhry1, Rehmat Jan2, Abdah Akim3

  • 1Institute of Marine Biotechnology, University Malaysia Terengganu, 21030 Kuala Terengganu, Malaysia.

Insights

Natural compounds offer promising anticancer agents for breast cancer treatment, targeting key pathways like apoptosis and cell cycle arrest. Further research into phytochemicals and their analogs could lead to more effective chemotherapy drugs.

Area of Science:

  • Oncology
  • Pharmacology
  • Natural Product Chemistry

Background:

  • Conventional breast cancer treatments (chemotherapy, radiotherapy) face challenges with efficacy and patient survival rates.
  • There is a critical need for novel anticancer agents with improved therapeutic potential.
  • Natural resources, including plants and marine organisms, represent a rich source for discovering new drug candidates.

Purpose of the Study:

  • To review the role of natural products, specifically phytochemicals, in the development of novel anticancer therapeutics.
  • To highlight the molecular targets and mechanisms of action of plant extracts, fractions, and isolated compounds against cancer.
  • To explore the potential of phytochemicals and their analogs as future candidates for anticancer chemotherapy.

Main Methods:

  • Screening of natural plant extracts and fractions for anticancer activity.
  • Isolation and characterization of bioactive phytochemicals from these extracts.
  • Mechanistic studies to elucidate the molecular targets and pathways affected by these compounds.

Main Results:

  • Phytochemicals demonstrate significant anticancer effects through synergistic targeting of multiple signaling pathways.
  • Identified mechanisms include induction of apoptosis, modulation of cell cycle arrest, and inhibition of invasion and metastasis.
  • Various pro-survival signaling pathways are also targeted by these natural compounds.

Conclusions:

  • Natural products, particularly phytochemicals, show considerable promise as a source for developing new anticancer drugs.
  • Understanding the molecular mechanisms of these compounds is crucial for their advancement into clinical applications.
  • Phytochemicals and their modified analogs are identified as potential future candidates for effective breast cancer chemotherapy.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.2K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.9K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
3.1K